SA 1
Tuesday, April 7, 2026
27.3
C
Bengaluru
Hot topics
Has Indian Pharma Seen The Longevity Tsunami Coming?
Why India Must Urgently Reinvent Healthcare for a 100-Year...
What about Indian Pharma?
Articles by K. Hariram, Vivek Hattangadi, Soham Wagh, Dr. Rajshri Jobanputra, and Rashesh Patel
Inspirational Frontline Leadership
The last issue of 2016, with articles from K. Hariram and Vivek Hattangadi and new authors, Dr. Ashwin Bonde and Diksha Fouzdar. Diksha's article is the highlight of this issue - an in-depth look at how to embed compliance in the very DNA of a pharma company.
The Rise and Fall of Core Parenterals – India’s IV Fluid Pioneer
Background
Core Healthcare Ltd., popularly known as Core Parenterals, was...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
Hot topics
Boehringer Ingelheim India focuses on partnerships in NCD management
Addressing the media at a roundtable this morning, Vani Manja, Managing Director, Boehringer Ingelheim India said, “Boehringer Ingelheim India aspires to be amongst the top five multinational pharmaceutical companies in India over the next few years. We have been enabling access to our innovator products to patients across India and the neighbouring markets in the diabetes, cardiovascular, stroke and respiratory diseases segments. Our plan in these therapy areas is to build sustainable partnerships to ensure an ecosystem of access and care for patients. We have initiated action in that direction.”
From VUCA to TACO: Thriving in a Chaotic World
From VUCA to TACO: Thriving in a Chaotic World
Leaders...
Rethinking Healthcare Communications for the Indian Context
Indian healthcare is sometimes an enigma: on one hand...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Newsletter
Get important news delivered directly to your inbox and stay connected!